- Home
- MBOT
as 11-25-2025 3:42pm EST
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | HINGHAM |
| Market Cap: | 128.9M | IPO Year: | N/A |
| Target Price: | $12.00 | AVG Volume (30 days): | 1.9M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.39 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.93 - $4.67 | Next Earning Date: | 11-12-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 1107.73% |
Latest Microbot Medical Inc. News
MBOT Breaking Stock News: Dive into MBOT Ticker-Specific Updates for Smart Investing
GlobeNewswire
21 days ago
Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.
Zacks
a month ago
Down 28.2% in 4 Weeks, Here's Why You Should You Buy the Dip in Microbot Medical (MBOT)
GlobeNewswire
a month ago
Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting
GlobeNewswire
a month ago
Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System
GlobeNewswire
2 months ago
Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
Simply Wall St.
5 months ago
Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth
GlobeNewswire
5 months ago
Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China
Zacks
5 months ago
Microbot Medical (MBOT) Upgraded to Buy: What Does It Mean for the Stock?
Compare MBOT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MBOT Microbot Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.